-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Friday's After-Market Session
Share
Listen to the news

Gainers

  • iTonic Holdings (NASDAQ:ITOC) stock increased by 8.1% to $0.3 during Friday's after-market session. The market value of their outstanding shares is at $5.1 million.
  • Advanced Biomed (NASDAQ:ADVB) shares rose 6.82% to $5.45. The market value of their outstanding shares is at $8.0 million.
  • Brookdale Senior Living (NYSE:BKD) shares rose 6.39% to $15.97. The company's market cap stands at $3.6 billion.
  • Nexalin Technology (NASDAQ:NXL) stock increased by 5.97% to $0.5. The market value of their outstanding shares is at $9.9 million.
  • Cosmos Health (NASDAQ:COSM) stock increased by 5.62% to $0.25. The company's market cap stands at $17.4 million.
  • Bruker (NASDAQ:BRKR) shares rose 4.79% to $61.02. The company's market cap stands at $9.0 billion.

Losers

  • Valion Bio (NASDAQ:VBIO) stock declined by 15.7% to $0.42 during Friday's after-market session. The company's market cap stands at $1.5 million.
  • ALPS Group (NASDAQ:ALPS) stock decreased by 7.36% to $0.44. The market value of their outstanding shares is at $74.0 million.
  • Bluejay Diagnostics (NASDAQ:BJDX) shares decreased by 6.21% to $1.36. The market value of their outstanding shares is at $1.3 million.
  • China Pharma Holding (AMEX:CPHI) shares fell 5.97% to $1.03. The company's market cap stands at $49.8 million.
  • Gelteq (NASDAQ:GELS) shares declined by 5.64% to $0.58. The company's market cap stands at $6.3 million.
  • Telomir Pharmaceuticals (NASDAQ:TELO) stock fell 5.41% to $1.05. The market value of their outstanding shares is at $81.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending